[1]
2009. From cell biology to therapy: lenalidomide in relapsed/refractory multiple myeloma.
Hematology Meeting Reports (formerly Haematologica Reports)
. 2, 5 (Jun. 2009). DOI:
https://doi.org/10.4081/hmr.v2i5.745
.